BioSpace News Archive

Business

Verily and ResMed Team Up on Joint Venture to Study Sleep Apnea

Verily will team up with San Diego-based ResMed, a company that specializes in the treatment of sleep disorders, to launch a new joint business venture to address sleep apnea and other sleeping disorders.

July 13, 2018
·
3 min read
·
Alex Keown
Genetown

July 13 Research Roundup: Gene Therapy for Cholesterol, Beta-Thalassemia, and Kidney Disease, and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them from gene therapy for cholesterol to kidney disease and more.

July 13, 2018
·
6 min read
·
Mark Terry
Policy

Trump Nabs Win Over Pfizer But Other Companies Continue With Price Increases

President Trump was able to declare a small victory in the arena of drug pricing earlier this week when Pfizer opted to delay its second price-hike of the year. Other companies though have not followed suit and have gone through with price increases for their drugs.

July 13, 2018
·
3 min read
·
Alex Keown
Business

ShangPharma Innovation Incubator Expansion Is Taking Strong Root in the Bay Area

In March venture capital firm ShangPharma Innovations announced its plans to expand its life sciences incubator in San Francisco by 40 percent, including state-of-the-art laboratory infrastructure upgrades to its facility. That investment is paying off as the incubator is growing.

July 13, 2018
·
2 min read
·
Alex Keown
Drug Development

Amgen and UCB Take Another Shot at Osteoporosis Drug

Amgen and UCB resubmitted their Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for Evenity (romosozumab).

July 13, 2018
·
2 min read
·
Mark Terry
Policy

Novartis and Trump Attorney Michael Cohen Had Deeper Relationship Than Disclosed: Report

Novartis and Michael Cohen, attorney to President Donald Trump, had a much deeper relationship than has been previously disclosed and was selling access to the White House, a new report issued by Senate Democrats alleges.

July 13, 2018
·
3 min read
·
Alex Keown
Policy

St. Louis Jury Awards $4.7 Billion in Punitive Damages in J&J Asbestos Lawsuit

In a particularly large result, a St. Louis jury awarded almost $4.7 billion in total damages to 22 women and their families in a lawsuit against Johnson & Johnson.

July 13, 2018
·
3 min read
·
Mark Terry
Drug Development

FDA Lifts Clinical Hold on Advaxis Drug, Shares Jump in Morning Trading

Shares of Advaxis are skyrocketing this morning after the company announced the U.S. Food and Drug Administration lifted the clinical hold on its Investigational New Drug Application for a Phase I/II cancer study.

July 13, 2018
·
2 min read
·
Alex Keown
Deals

Justice Department Gives CVS and Aetna Deal a Go-Ahead

The U.S. Justice Department announced yesterday that it will not challenge the merger of CVS Health Corp and health insurer Aetna.

July 13, 2018
·
2 min read
·
Mark Terry
Policy

Scandal-Plagued Exec Leaves Human Longevity

Saturnino “Nino” Fanlo, chief financial officer and chief operations officer of Human Longevity (HLI), has left the company. Fanlo was implicated in a scandal at his previous employer, online lender Social Finance (SoFi).

July 13, 2018
·
3 min read
·
Mark Terry